NextCell Pharma AB (NXTCL) — Net Asset Quality Index
NextCell Pharma AB (NXTCL) has a Net Asset Quality Index of 86.5% as of August 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr76.73 Million minus total liabilities of Skr10.34 Million yields net assets of Skr66.39 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of NextCell Pharma AB to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
NextCell Pharma AB Net Asset Quality Index Over Time (2015–2025)
This chart shows how NextCell Pharma AB's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of August 2025, the index stands at 86.5%, representing net assets of Skr66.39 Million against total assets of Skr76.73 Million SEK. Explore NextCell Pharma AB (NXTCL) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for NextCell Pharma AB (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for NextCell Pharma AB from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of NextCell Pharma AB.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.5% | Skr66.39 Million | Skr76.73 Million | Skr10.34 Million | ▲ +3.4 pp |
| 2024 | 83.2% | Skr67.60 Million | Skr81.29 Million | Skr13.69 Million | ▼ -2.1 pp |
| 2023 | 85.3% | Skr75.73 Million | Skr88.83 Million | Skr13.10 Million | ▼ -7.4 pp |
| 2022 | 92.7% | Skr115.54 Million | Skr124.66 Million | Skr9.12 Million | ▼ -3.8 pp |
| 2021 | 96.4% | Skr150.09 Million | Skr155.63 Million | Skr5.53 Million | ▲ +8.4 pp |
| 2020 | 88.1% | Skr26.22 Million | Skr29.77 Million | Skr3.56 Million | ▲ +2.1 pp |
| 2019 | 85.9% | Skr22.96 Million | Skr26.72 Million | Skr3.76 Million | ▲ +26.7 pp |
| 2018 | 59.2% | Skr5.04 Million | Skr8.51 Million | Skr3.47 Million | ▼ -29.0 pp |
| 2017 | 88.2% | Skr19.07 Million | Skr21.63 Million | Skr2.55 Million | ▲ +16.7 pp |
| 2016 | 71.5% | Skr6.76 Million | Skr9.47 Million | Skr2.70 Million | ▼ -7.6 pp |
| 2015 | 79.1% | Skr9.77 Million | Skr12.36 Million | Skr2.59 Million | — |